Your browser doesn't support javascript.
loading
Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination - a case study.
Ravlo, Erlend; Ianevski, Aleksandr; Starheim, Eirin; Wang, Wei; Ji, Ping; Lysvand, Hilde; Smura, Teemu; Kivi, Gaily; Voolaid, Maia-Liisa; Plaan, Kati; Ustav, Mart; Ustav, Mart; Zusinaite, Eva; Tenson, Tanel; Kurg, Reet; Oksenych, Valentyn; Walstad, Kirsti; Nordbø, Svein Arne; Kaarbø, Mari; Ernits, Karin; Bjørås, Magnar; Kainov, Denis E; Fenstad, Mona Høysæter.
Afiliación
  • Ravlo E; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
  • Ianevski A; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
  • Starheim E; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
  • Wang W; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
  • Ji P; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
  • Lysvand H; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
  • Smura T; Department of Virology, University of Helsinki, Helsinki, Finland; HUS Diagnostic Center, Clinical Microbiology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Kivi G; Icosagen Cell Factory OÜ, Tartu, Estonia.
  • Voolaid ML; Icosagen Cell Factory OÜ, Tartu, Estonia.
  • Plaan K; Icosagen Cell Factory OÜ, Tartu, Estonia.
  • Ustav M; Icosagen Cell Factory OÜ, Tartu, Estonia.
  • Ustav M; Icosagen Cell Factory OÜ, Tartu, Estonia.
  • Zusinaite E; Institute of Technology, University of Tartu, Tartu, Estonia.
  • Tenson T; Institute of Technology, University of Tartu, Tartu, Estonia.
  • Kurg R; Institute of Technology, University of Tartu, Tartu, Estonia.
  • Oksenych V; Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Walstad K; Department of Immunology and Transfusion Medicine, St. Olavs Hospital, Trondheim, Norway.
  • Nordbø SA; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway; Department of Immunology and Transfusion Medicine, St. Olavs Hospital, Trondheim, Norway.
  • Kaarbø M; Department of Microbiology, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Ernits K; Department of Experimental Medicine, University of Lund, Lund, Sweden.
  • Bjørås M; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway; Department of Microbiology, Oslo University Hospital and University of Oslo, Oslo, Norway; Centre for Embryology and Healthy Development, University of Oslo and Oslo University Ho
  • Kainov DE; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway; Institute of Technology, University of Tartu, Tartu, Estonia; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland. Electronic address: denis.kainov
  • Fenstad MH; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway; Department of Immunology and Transfusion Medicine, St. Olavs Hospital, Trondheim, Norway.
Int J Infect Dis ; 137: 75-78, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37852599
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Noruega
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Noruega